Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda
Clinical trial NCT07408297 · COMPLETED
Trial details
- NCT number
- NCT07408297
- Sponsor
- Victoria Biomedical Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-06-27
- Enrollment
- 1919
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.